Conceptual exploration of engineered hematopoietic immunity in transplantation, suggesting new therapeutic approaches.
The authors declare no conflicts of interest. Data sharing not applicable to this article as no datasets were generated or analyzed during the current study. Figure S1: From graft-versus-leukemia immunity to engineered hematopoietic immunity: a conceptual continuum of immune control. Figure S2: CAR-NK cells as a conceptual bridge between transplantation biology and synthetic immune engineering. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
No takes yet. Share an insight, caveat, or question.
Morabito et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: